This trial will test whether a tailored, health communication intervention can increase HPV vaccination rates among underserved, vaccine hesitant parents.
3 Primary · 1 Secondary · Reporting Duration: 6 months
Active Control
Experimental Treatment
244 Total Participants · 2 Treatment Groups
Primary Treatment: Mobile Phone-Based Web-Page: HPV vaccine · No Placebo Group · N/A
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: